Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


18.03.2019

1 Diagn Cytopathol
2 Endocr J
5 J Clin Endocrinol Metab
1 J Nucl Med
1 Nat Rev Endocrinol
1 Ophthalmic Plast Reconstr Surg
1 PLoS One
1 Surgery
5 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Diagn Cytopathol

  1. AYDOGAN BI, Sahin M, Ceyhan K, Deniz O, et al
    The influence of thyroid nodule size on the diagnostic efficacy and accuracy of ultrasound guided fine-needle aspiration cytology.
    Diagn Cytopathol. 2019 Mar 12. doi: 10.1002/dc.24170.
    PubMed     Text format     Abstract available


    Endocr J

  2. KOSHIKAWA T, Fujita N, Ueda N, Ota Y, et al
    Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.
    Endocr J. 2019 Mar 14. doi: 10.1507/endocrj.EJ18-0525.
    PubMed     Text format     Abstract available

  3. UEDA K, Kiyota A, Tsuchida M, Okazaki M, et al
    Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine.
    Endocr J. 2019 Mar 8. doi: 10.1507/endocrj.EJ18-0469.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  4. RUSSELL JO, Razavi CR, Shaear M, Chen LW, et al
    Transoral Vestibular Thyroidectomy: Current State of Affairs and Considerations for the Future.
    J Clin Endocrinol Metab. 2019 Mar 12. pii: 5372734. doi: 10.1210/jc.2019-00116.
    PubMed     Text format     Abstract available

  5. LICENZIATI MR, Valerio G, Vetrani I, De Maria G, et al
    Altered thyroid function and structure in overweight and obese children and adolescents: reversal after weight loss.
    J Clin Endocrinol Metab. 2019 Mar 15. pii: 5380480. doi: 10.1210/jc.2018-02399.
    PubMed     Text format     Abstract available

  6. TUTTLE RM, Alzahrani AS
    Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-up.
    J Clin Endocrinol Metab. 2019 Mar 15. pii: 5380478. doi: 10.1210/jc.2019-00177.
    PubMed     Text format     Abstract available


  7. CORRIGENDUM FOR "Pilot Dose Comparison of Apatinib in Chinese Patients with Progressive Radioiodine-Refractory Differentiated Thyroid Cancer".
    J Clin Endocrinol Metab. 2019 Mar 12. pii: 5372728. doi: 10.1210/jc.2019-00546.
    PubMed     Text format    

  8. DEANDREA M, Trimboli P, Garino F, Mormile A, et al
    Long Term Efficacy of a Single Session RFA of Benign Thyroid Nodules: A Longitudinal 5-Year Observational Study.
    J Clin Endocrinol Metab. 2019 Mar 12. pii: 5372729. doi: 10.1210/jc.2018-02808.
    PubMed     Text format     Abstract available


    J Nucl Med

  9. ROLL W, Markwardt NA, Masthoff M, Helfen A, et al
    Multispectral optoacoustic tomography of benign and malignant thyroid disorders - a pilot study.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.222174. doi: 10.2967/jnumed.118.222174.
    PubMed     Text format     Abstract available


    Nat Rev Endocrinol

  10. STARLING S
    Key pathways revealed in rare thyroid cancer.
    Nat Rev Endocrinol. 2019 Mar 13. pii: 10.1038/s41574-019-0193.
    PubMed     Text format    


    Ophthalmic Plast Reconstr Surg

  11. COPPERMAN T, Idowu OO, Kersten RC, Vagefi MR, et al
    Subcutaneous Tocilizumab for Thyroid Eye Disease: Simplified Dosing and Delivery.
    Ophthalmic Plast Reconstr Surg. 2019 Mar 8. doi: 10.1097/IOP.0000000000001346.
    PubMed     Text format     Abstract available


    PLoS One

  12. GASIOR-PERCZAK D, Palyga I, Szymonek M, Kowalik A, et al
    The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    PLoS One. 2018;13:e0204668.
    PubMed     Text format     Abstract available


    Surgery

  13. ZHAO H, Huang T, Li H
    Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Surgery. 2019 Mar 12. pii: S0039-6060(19)30056.
    PubMed     Text format     Abstract available


    Thyroid

  14. JEONG JH, Oh JM, Jeong SY, Lee SW, et al
    Combination treatment with BRAFV600E inhibitor, vemurafenib, and BH3 mimetic, navitoclax, for BRAF mutant thyroid carcinoma.
    Thyroid. 2019 Mar 14. doi: 10.1089/thy.2018.0511.
    PubMed     Text format     Abstract available

  15. WONG KS, Lorch J, Alexander EK, Nehs MA, et al
    Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
    Thyroid. 2019 Mar 14. doi: 10.1089/thy.2018.0716.
    PubMed     Text format     Abstract available

  16. PICCARDO A, Trimboli P, Puntoni M, Foppiani L, et al
    Role of 18F-FCH PET/CT to detect structural relapse in high risk Differentiated Thyroid Cancer patients.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0552.
    PubMed     Text format     Abstract available

  17. AHN J, Song E, Oh HS, Song DE, et al
    Low lymphocyte-to-monocyte ratios are associated with poor overall survival in anaplastic thyroid carcinoma patients.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0684.
    PubMed     Text format     Abstract available

  18. OH HS, Kwon H, Song E, Jeon M, et al
    Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0609.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: